Cardiome announced positive results from a Phase 2a pilot study for vernakalant (oral) in September 2006. A Phase 2b study for vernakalant (oral) is ongoing. In April 2007 Cardiome acquired exclusive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback